Index of reports
> Cases with Insomnia (23)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Invega (Paliperidone) where reactions include insomnia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Invega side effects in male
Reported by a physician from Japan on 2012-08-06
Patient: male, weighing 57.0 kg (125.4 pounds)
Reactions: Malaise, Insomnia, Abnormal Behaviour, Somnolence
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2011-12-26
End date: 2012-01-18
Invega
Administration route: Oral
Start date: 2012-01-19
End date: 2012-02-06
Other drugs received by patient: Zoloft; Nitrazepam; Alprazolam; Silece; Diazepam; Doral
Possible Invega side effects in male
Reported by a physician from Japan on 2012-08-06
Patient: male, weighing 42.0 kg (92.4 pounds)
Reactions: Pneumonia, Ileus, Insomnia
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Start date: 2011-04-16
End date: 2011-04-20
Risperdal
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-04-08
End date: 2011-04-15
Zyprexa
Administration route: Oral
Indication: Schizophrenia, Disorganised Type
Invega
Administration route: Oral
Start date: 2011-04-16
End date: 2011-04-20
Invega
Administration route: Oral
Start date: 2011-04-26
Risperdal
Administration route: Oral
Start date: 2011-04-21
End date: 2011-04-25
Invega
Administration route: Oral
Indication: Schizophrenia, Disorganised Type
Start date: 2011-04-21
End date: 2011-04-25
Other drugs received by patient: Clonazepam; Flunitrazepam; Magmitt; Phenobarbital TAB; Depakene; Diazepam; Nelurolen; Clonazepam; Magmitt; Clonazepam; Clonazepam
Possible Invega side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-06
Patient: female, weighing 54.4 kg (119.7 pounds)
Reactions: Treatment Noncompliance, Suicidal Ideation, Speech Disorder, Thinking Abnormal, Unevaluable Event, Flashback, Crying, Rhinorrhoea, Rash, Drug Prescribing Error, LIP Ulceration, Abnormal Weight Gain, Discomfort, Activities of Daily Living Impaired, Insomnia, Disturbance in Attention, Inappropriate Affect
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2012-05-15
End date: 2012-05-01
Invega
Dosage: half tablet of 6 mg
Administration route: Oral
Start date: 2012-05-01
Lamictal
Administration route: Oral
Start date: 2012-05-01
End date: 2012-06-01
Lamictal
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2012-06-01
End date: 2012-06-01
Invega
Administration route: Oral
Start date: 2011-05-01
End date: 2012-05-01
Possible Invega side effects in female
Reported by a physician from Belgium on 2012-06-29
Patient: female, weighing 97.0 kg (213.4 pounds)
Reactions: Psychotic Disorder, Overdose, Insomnia, Mental Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Schizophrenia
Paliperidone
Indication: Product Used FOR Unknown Indication
Zyprexa
Administration route: Oral
Indication: Schizophrenia
Risperdal Consta
Indication: Product Used FOR Unknown Indication
Possible Invega side effects in female
Reported by a consumer/non-health professional from United States on 2012-06-29
Patient: female, weighing 54.4 kg (119.7 pounds)
Reactions: Insomnia, Drug Prescribing Error, Suicidal Ideation, Abnormal Weight Gain, Discomfort
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2012-05-15
End date: 2012-05-01
Invega
Dosage: half tablet of 6 mg
Administration route: Oral
Invega
Administration route: Oral
Start date: 2011-05-01
End date: 2012-05-01
Possible Invega side effects in female
Reported by a physician from Belgium on 2012-05-29
Patient: female, weighing 97.0 kg (213.4 pounds)
Reactions: Overdose, Psychotic Disorder, Insomnia, Mental Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Paliperidone
Indication: Product Used FOR Unknown Indication
Risperdal Consta
Indication: Product Used FOR Unknown Indication
Invega
Administration route: Oral
Indication: Schizophrenia
Zyprexa
Administration route: Oral
Indication: Schizophrenia
Possible Invega side effects in female
Reported by a consumer/non-health professional from United States on 2012-04-25
Patient: female, weighing 73.5 kg (161.7 pounds)
Reactions: Agitation, Hallucination, Auditory, Insomnia, Mental Disorder, Adverse Event, Abnormal Weight Gain, Lactation Disorder
Drug(s) suspected as cause:
Invega Sustenna
Indication: Hallucination, Auditory
Start date: 2011-12-08
Invega
Administration route: Oral
Indication: Hallucination, Auditory
Start date: 2011-12-08
Possible Invega side effects in female
Reported by a consumer/non-health professional from United States on 2012-04-06
Patient: female, weighing 73.5 kg (161.7 pounds)
Reactions: Hallucination, Auditory, Insomnia, Abnormal Weight Gain
Drug(s) suspected as cause:
Invega Sustenna
Indication: Hallucination, Auditory
Start date: 2011-12-01
Invega
Administration route: Oral
Indication: Hallucination, Auditory
Start date: 2011-12-01
Possible Invega side effects in male
Reported by a physician from Japan on 2012-04-02
Patient: male, weighing 70.0 kg (154.0 pounds)
Reactions: Insomnia, Inappropriate Affect
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Schizophrenia
Start date: 2011-07-04
Invega
Administration route: Oral
Start date: 2011-06-08
End date: 2011-06-10
Invega
Administration route: Oral
Start date: 2011-06-11
End date: 2011-07-03
Other drugs received by patient: Quazepam; Depakene; Sennoside; Depakene
Possible Invega side effects in female
Reported by a physician from Japan on 2012-03-29
Patient: female, weighing 54.0 kg (118.8 pounds)
Reactions: Insomnia, Dysuria, Parkinsonism
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Start date: 2011-10-03
End date: 2011-10-23
Risperdal
Administration route: Oral
End date: 2011-09-25
Risperdal
Administration route: Oral
Start date: 2011-10-24
End date: 2011-11-27
Invega
Administration route: Oral
Indication: Schizophrenia, Disorganised Type
Start date: 2011-10-17
Risperdal
Administration route: Oral
Indication: Schizophrenia, Disorganised Type
Start date: 2011-09-26
End date: 2011-09-29
Risperdal
Administration route: Oral
Start date: 2011-09-30
End date: 2011-10-02
Invega
Administration route: Oral
Start date: 2011-09-25
End date: 2011-10-16
Risperdal
Administration route: Oral
Start date: 2011-11-28
End date: 2011-12-05
Other drugs received by patient: Nelurolen; Gasmotin; Konsuben; Magmitt; Flunitrazepam; Sorentmin; Pursennid; Rebamipide; Depakene; Trihexyphenidyl HCL
Possible Invega side effects in 28 year old male
Reported by a consumer/non-health professional from Japan on 2012-03-21
Patient: 28 year old male
Reactions: Phobia, Cluttering, Hallucination, Auditory, Delusion, Myalgia, Weight Increased, Fatigue, Anger, Drug Effect Decreased, Dystonia, Blepharospasm, Hypoaesthesia, Convulsion, Aggression, Irritability, Panic Attack, Insomnia, Ocular Hyperaemia, Nervous System Disorder, Tardive Dyskinesia, Withdrawal Syndrome, Extrapyramidal Disorder
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Chlorpromazine HCL
Indication: Product Used FOR Unknown Indication
Risperdal
Administration route: Oral
Indication: Schizophrenia
End date: 2011-02-15
Risperdal
Administration route: Oral
Invega
Administration route: Oral
Risperdal
Administration route: Oral
Invega
Administration route: Oral
Start date: 2011-02-19
Risperdal
Administration route: Oral
Start date: 2011-02-21
Chlorpromazine HCL
Invega
Administration route: Oral
Indication: Schizophrenia
Invega
Administration route: Oral
Invega
Administration route: Oral
Start date: 2011-02-16
Risperdal
Administration route: Oral
Risperdal
Administration route: Oral
Other drugs received by patient: Clonazepam; Artane; Dogmatyl; Tegretol
Possible Invega side effects in male
Reported by a physician from Japan on 2012-03-16
Patient: male, weighing 70.0 kg (154.0 pounds)
Reactions: Insomnia, Inappropriate Affect
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Schizophrenia
Start date: 2011-07-04
Invega
Administration route: Oral
Start date: 2011-06-08
End date: 2011-06-10
Invega
Administration route: Oral
Start date: 2011-06-11
End date: 2011-07-03
Other drugs received by patient: Quazepam; Depakene; Sennoside; Depakene
Possible Invega side effects in male
Reported by a physician from Australia on 2012-03-13
Patient: male
Reactions: Mania, Insomnia
Drug(s) suspected as cause:
Invega
Possible Invega side effects in female
Reported by a physician from Japan on 2012-03-08
Patient: female, weighing 54.0 kg (118.8 pounds)
Reactions: Insomnia, Dysuria, Parkinsonism
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Start date: 2011-09-26
End date: 2011-09-29
Invega
Administration route: Oral
Indication: Schizophrenia, Disorganised Type
Start date: 2011-10-17
Invega
Administration route: Oral
Start date: 2011-09-25
End date: 2011-10-16
Risperdal
Administration route: Oral
Indication: Schizophrenia, Disorganised Type
End date: 2011-09-25
Risperdal
Administration route: Oral
Start date: 2011-11-28
End date: 2011-12-05
Risperdal
Administration route: Oral
Start date: 2011-10-24
End date: 2011-11-27
Risperdal
Administration route: Oral
Start date: 2011-10-03
End date: 2011-10-23
Risperdal
Administration route: Oral
Start date: 2011-09-30
End date: 2011-10-02
Other drugs received by patient: Rebamipide; Sorentmin; Flunitrazepam; Konsuben; Magmitt; Gasmotin; Depakene; Trihexyphenidyl HCL; Nelurolen; Pursennid
Possible Invega side effects in male
Reported by a physician from Australia on 2012-03-02
Patient: male
Reactions: Mania, Insomnia
Drug(s) suspected as cause:
Invega
Possible Invega side effects in female
Reported by a physician from Japan on 2012-02-27
Patient: female, weighing 54.0 kg (118.8 pounds)
Reactions: Dysuria, Insomnia, Parkinsonism
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Start date: 2011-10-24
End date: 2011-11-27
Risperdal
Administration route: Oral
Start date: 2011-10-03
End date: 2011-10-23
Invega
Administration route: Oral
Indication: Schizophrenia, Disorganised Type
Start date: 2011-10-17
Invega
Administration route: Oral
Start date: 2011-09-25
End date: 2011-10-16
Risperdal
Administration route: Oral
Start date: 2011-11-28
End date: 2011-12-05
Risperdal
Administration route: Oral
Indication: Schizophrenia, Disorganised Type
End date: 2011-09-25
Risperdal
Administration route: Oral
Start date: 2011-09-26
End date: 2011-09-29
Risperdal
Administration route: Oral
Start date: 2011-09-30
End date: 2011-10-02
Other drugs received by patient: Gasmotin; Sorentmin; Magmitt; Depakene; Trihexyphenidyl HCL; Nelurolen; Rebamipide; Flunitrazepam; Pursennid; Konsuben
Possible Invega side effects in 41 year old female
Reported by a consumer/non-health professional from United States on 2012-02-10
Patient: 41 year old female, weighing 108.0 kg (237.5 pounds)
Reactions: Gingival Pain, Insomnia, Ear Pain
Drug(s) suspected as cause:
Invega
Possible Invega side effects in 51 year old male
Reported by a physician from Japan on 2012-02-09
Patient: 51 year old male
Reactions: Rhabdomyolysis, Insomnia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Schizophrenia
Start date: 2011-06-29
Invega
Administration route: Oral
Start date: 2011-06-23
End date: 2011-06-28
Other drugs received by patient: Lendormin; Nitrazepam; Dogmatyl
Possible Invega side effects in 26 year old female
Reported by a consumer/non-health professional from United States on 2012-01-03
Patient: 26 year old female
Reactions: Fatigue, Drug Ineffective, Increased Appetite, Heart Rate Increased, Insomnia, Anger, Abnormal Loss of Weight, Stress
Drug(s) suspected as cause:
Invega
Administration route: Oral
Start date: 2011-12-22
Invega
Administration route: Oral
Indication: Bipolar I Disorder
Other drugs received by patient: TPN; Bilatin; Flax Seed OIL; Eveninig Primrose OIL; Vitamin D; Horse Chestnut Extract; 5 HTP; Hops
Possible Invega side effects in male
Reported by a consumer/non-health professional from United States on 2011-11-16
Patient: male, weighing 93.0 kg (204.6 pounds)
Reactions: Product Quality Issue, Dermatitis, Feeling Hot, Insomnia, Abnormal Behaviour, Skin Reaction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invega
Possible Invega side effects in 28 year old male
Reported by a consumer/non-health professional from Japan on 2011-11-14
Patient: 28 year old male
Reactions: Phobia, Cluttering, Hallucination, Auditory, Delusion, Weight Increased, Myalgia, Fatigue, Anger, Blepharospasm, Dystonia, Hypoaesthesia, Aggression, Convulsion, Panic Attack, Ocular Hyperaemia, Insomnia, Nervous System Disorder, Withdrawal Syndrome, Extrapyramidal Disorder, Tardive Dyskinesia
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Schizophrenia
Start date: 2011-02-19
Invega
Administration route: Oral
Risperdal
Administration route: Oral
Start date: 2011-02-21
Risperdal
Administration route: Oral
Invega
Administration route: Oral
Risperdal
Administration route: Oral
Risperdal
Administration route: Oral
Risperdal
Administration route: Oral
Indication: Schizophrenia
End date: 2011-02-15
Invega
Administration route: Oral
Start date: 2011-02-16
Chlorpromazine HCL
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Tegretol; Clonazepam; Artane; Dogmatyl
Possible Invega side effects in female
Reported by a consumer/non-health professional from United States on 2011-10-27
Patient: female, weighing 113.4 kg (249.5 pounds)
Reactions: Vomiting, Hallucination, Visual, Nausea, Hallucination, Auditory, Insomnia, Depression, Impaired Gastric Emptying
Drug(s) suspected as cause:
Invega
Administration route: Oral
Start date: 2011-10-12
End date: 2011-10-19
Invega
Administration route: Oral
Start date: 2011-09-30
End date: 2011-10-11
Invega
Administration route: Oral
Start date: 2011-09-23
End date: 2011-09-29
Invega
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2011-06-01
End date: 2011-09-22
Other drugs received by patient: Ativan; Effexor XR; Lamictal; Dilaudid
Possible Invega side effects in 51 year old male
Reported by a physician from Japan on 2011-10-17
Patient: 51 year old male
Reactions: Rhabdomyolysis, Insomnia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Schizophrenia
Start date: 2011-06-29
Invega
Administration route: Oral
Start date: 2011-06-23
End date: 2011-06-28
Other drugs received by patient: Lendormin; Dogmatyl
|